Direct Evidences for Sympathetic Hyperactivity and Baroreflex Impairment in Tako Tsubo Cardiopathy

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Vaccaro, Angelica ^a,c   Despas, Fabien ^a,b,c   Delmas, Clement ^a,c   Lairez, Olivier ^a,b,c   Lambert, Elisabeth ^d   Lambert, Gavin ^d   Labrunee, Marc ^a,b,c   Guiraud, Thibaut ^a,b   Esler, Murray ^d   Galinier, Michel ^a,b,c   Senard, Jean Michel ^a,b,c   Pathak, Atul ^a,b,c,d  

^a University Hospital of Toulouse   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

AGE; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; OXYGEN SATURATION; PATHOPHYSIOLOGY; PRESSORECEPTOR REFLEX; SEX; SYMPATHETIC TONE; TAKOTSUBO CARDIOMYOPATHY; VERY ELDERLY;

AGED, 80 AND OVER; BAROREFLEX; BLOOD PRESSURE; CASE-CONTROL STUDIES; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MUSCLES; SYMPATHETIC NERVOUS SYSTEM; TAKOTSUBO CARDIOMYOPATHY;

EID: 84899736538     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093278     Document Type: Article

References (48)

1. Sato H, Tateishi H, Dote K, Uchida T, Ishihara M (1990) Tako-tsubo-like left ventricular dysfunction due to multivessel coronary spasm; Kodama K hK, Hori M, editor. Tokyo, Japan: Kagakuhyoronsha Publishing Co. 56-64 p.
2. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, et al. (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113: 1807-1816. (Pubitemid 43958474)
3. Bybee KA, Prasad A, Barsness GW, Lerman A, Jaffe AS, et al. (2004) Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome. Am J Cardiol 94: 343-346. (Pubitemid 38962701)
4. Elian D, Osherov A, Matetzky S, Hod H, Guetta V, et al. (2006) Left ventricular apical ballooning: not an uncommon variant of acute myocardial infarction in women. Clin Cardiol 29: 9-12. (Pubitemid 43130879)
5. Pilliere R, Mansencal N, Digne F, Lacombe P, Joseph T, et al. (2006) Prevalence of tako-tsubo syndrome in a large urban agglomeration. Am J Cardiol 98: 662-665. (Pubitemid 44233466)
6. Parodi G, Del Pace S, Carrabba N, Salvadori C, Memisha G, et al. (2007) Incidence, clinical findings, and outcome of women with left ventricular apical ballooning syndrome. Am J Cardiol 99: 182-185. (Pubitemid 46072752)
7. Azzarelli S, Galassi AR, Amico F, Giacoppo M, Argentino V, et al. (2006) Clinical features of transient left ventricular apical ballooning. Am J Cardiol 98: 1273-1276. (Pubitemid 44584120)
8. Schneider B, Athanasiadis A, Stollberger C, Pistner W, Schwab J, et al. (2013) Gender differences in the manifestation of tako-tsubo cardiomyopathy. Int J Cardiol 166: 584-588.
9. Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, et al. (2004) Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med 141: 858-865. (Pubitemid 39601180)
10. Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, et al. (2006) Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J 27: 1523-1529. (Pubitemid 43954909)
11. Vizzardi E, D'Aloia A, Zanini G, Fiorina C, Chiari E, et al. (2010) Tako-tsubo-like left ventricular dysfunction: transient left ventricular apical ballooning syndrome. Int J Clin Pract 64: 67-74.
12. Pilgrim TM, Wyss TR (2008) Takotsubo cardiomyopathy or transient left ventricular apical ballooning syndrome: A systematic review. Int J Cardiol 124: 283-292. (Pubitemid 351313913)
13. Bielecka-Dabrowa A, Mikhailidis DP, Hannam S, Rysz J, Michalska M, et al. (2010) Takotsubo cardiomyopathy-the current state of knowledge. Int J Cardiol 142: 120-125.
14. Elesber AA, Prasad A, Lennon RJ, Wright RS, Lerman A, et al. (2007) Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol 50: 448-452. (Pubitemid 47088125)
15. Sharkey SW, Windenburg DC, Lesser JR, Maron MS, Hauser RG, et al. (2010) Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol 55: 333-341.
16. Burgdorf C, Kurowski V, Bonnemeier H, Schunkert H, Radke PW (2008) Long-term prognosis of the transient left ventricular dysfunction syndrome (Tako-Tsubo cardiomyopathy): focus on malignancies. Eur J Heart Fail 10: 1015-1019.
17. Lyon AR, Rees PS, Prasad S, Poole-Wilson PA, Harding SE (2008) Stress (Takotsubo) cardiomyopathy-a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. Nat Clin Pract Cardiovasc Med 5: 22-29.
18. Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, et al. (2005) Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352: 539-548. (Pubitemid 40204667)
19. Kume T, Kawamoto T, Okura H, Toyota E, Neishi Y, et al. (2008) Local release of catecholamines from the hearts of patients with tako-tsubo-like left ventricular dysfunction. Circ J 72: 106-108. (Pubitemid 351413336)
20. Akashi YJ, Nakazawa K, Sakakibara M, Miyake F, Musha H, et al. (2004) 123I-MIBG myocardial scintigraphy in patients with "takotsubo" cardiomyopathy. J Nucl Med 45: 1121-1127. (Pubitemid 47616042)
21. Abraham J, Mudd JO, Kapur NK, Klein K, Champion HC, et al. (2009) Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists. J Am Coll Cardiol 53: 1320-1325.
22. Grassi G, Bolla G, Quarti-Trevano F, Arenare F, Brambilla G, et al. (2008) Sympathetic activation in congestive heart failure: reproducibility of neuroadrenergic markers. Eur J Heart Fail 10: 1186-1191.
23. Eisenhofer G (2001) The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther 91: 35-62.
24. Despas F, Guerriero E, Galinier M, Senard J, Pathak A (2010) Limited prognostic value of cardiac metaiodobenzylguanidine in advanced heart failure. J Heart Lung Transplant 29: 591-592.
25. Waldenborg M, Soholat M, Kahari A, Emilsson K, Frobert O (2011) Multidisciplinary assessment of tako tsubo cardiomyopathy: a prospective case study. BMC Cardiovasc Disord 11: 14.
26. Kingwell BA, Thompson JM, Kaye DM, McPherson GA, Jennings GL, et al. (1994) Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation 90: 234-240. (Pubitemid 24203685)
27. Berganzo K, Ciordia R, Gomez-Esteban JC, Tijero B, Agundez M, et al. (2011) Tako-tsubo cardiomyopathy in a patient with bilateral lesions in the dorsal medulla. Clin Auton Res 21: 65-67.
28. Madhavan M, Prasad A (2010) Proposed Mayo Clinic criteria for the diagnosis of Tako-Tsubo cardiomyopathy and long-term prognosis. Herz.
29. Leimbach WN Jr., Wallin BG, Victor RG, Aylward PE, Sundlof G, et al. (1986) Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 73: 913-919. (Pubitemid 16102181)
30. Macefield VG, Rundqvist B, Sverrisdottir YB, Wallin BG, Elam M (1999) Firing properties of single muscle vasoconstrictor neurons in the sympathoexcitation associated with congestive heart failure. Circulation 100: 1708-1713. (Pubitemid 29485253)
31. Despas F, Detis N, Dumonteil N, Labrunee M, Bellon B, et al. (2009) Excessive sympathetic activation in heart failure with chronic renal failure: role of chemoreflex activation. J Hypertens 27: 1849-1854.
32. Despas F, Lambert E, Vaccaro A, Labrunee M, Franchitto N, et al. (2012) Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure. J Hypertens 30: 753-760.
33. Meyer T, Buss U, Herrmann-Lingen C (2010) Role of cardiac disease severity in the predictive value of anxiety for all-cause mortality. Psychosom Med 72: 9-15.
34. Brydon L, Strike PC, Bhattacharyya MR, Whitehead DL, McEwan J, et al. (2010) Hostility and physiological responses to laboratory stress in acute coronary syndrome patients. J Psychosom Res 68: 109-116.
35. Barton DA, Dawood T, Lambert EA, Esler MD, Haikerwal D, et al. (2007) Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J Hypertens 25: 2117-2124. (Pubitemid 47476310)
36. Spyer KM (1994) Annual review prize lecture. Central nervous mechanisms contributing to cardiovascular control. J Physiol 474: 1-19.
37. Nigmatullina RR, Kirillova VV, Jourjikiya RK, Mukhamedyarov MA, Kudrin VS, et al. (2009) Disrupted serotonergic and sympathoadrenal systems in patients with chronic heart failure may serve as new therapeutic targets and novel biomarkers to assess severity, progression and response to treatment. Cardiology 113: 277-286.
38. Yoshimura S, Toyoda K, Ohara T, Nagasawa H, Ohtani N, et al. (2008) Takotsubo cardiomyopathy in acute ischemic stroke. Ann Neurol 64: 547-554.
39. Scheitz JF, Mochmann HC, Witzenbichler B, Fiebach JB, Audebert HJ, et al. (2011) Takotsubo cardiomyopathy following ischemic stroke: a cause of troponin elevation. J Neurol.
40. Lavi S, Nevo O, Thaler I, Rosenfeld R, Dayan L, et al. (2007) Effect of aging on the cardiovascular regulatory systems in healthy women. Am J Physiol Regul Integr Comp Physiol 292: R788-793. (Pubitemid 46207731)
41. Norcliffe-Kaufmann LJ, Reynolds HR (2011) Afferent baroreflex failure and tako-tsubo cardiomyopathy. Clin Auton Res 21: 1-2.
42. Nef HM, Mollmann H, Troidl C, Kostin S, Voss S, et al. (2009) Abnormalities in intracellular Ca2+ regulation contribute to the pathomechanism of Tako-Tsubo cardiomyopathy. Eur Heart J 30: 2155-2164.
43. Akashi YJ, Nakazawa K, Sakakibara M, Miyake F, Koike H, et al. (2003) The clinical features of takotsubo cardiomyopathy. Qjm 96: 563-573. (Pubitemid 36987255)
44. Litvinov IV, Kotowycz MA, Wassmann S (2009) Iatrogenic epinephrine-induced reverse Takotsubo cardiomyopathy: direct evidence supporting the role of catecholamines in the pathophysiology of the "broken heart syndrome". Clin Res Cardiol 98: 457-462.
45. Volz HC, Erbel C, Berentelg J, Katus HA, Frey N (2009) Reversible left ventricular dysfunction resembling Takotsubo syndrome after self-injection of adrenaline. Can J Cardiol 25: e261-262.
46. Wallin BG, Esler M, Dorward P, Eisenhofer G, Ferrier C, et al. (1992) Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol 453: 45-58.
47. Chua TP, Ponikowski PP, Harrington D, Chambers J, Coats AJ (1996) Contribution of peripheral chemoreceptors to ventilation and the effects of their suppression on exercise tolerance in chronic heart failure. Heart 76: 483-489. (Pubitemid 27046841)
48. Franchitto N, Despas F, Labrunee M, Vaccaro A, Lambert E, et al. (2013) Cardiorenal anemia syndrome in chronic heart failure contributes to increased sympathetic nerve activity. Int J Cardiol.